Semaglutide Oral (Rybelsus)
Rybelsus · Oral Sema
Oral semaglutide with very low bioavailability; taken fasting.
Key takeaways
- Oral semaglutide (Rybelsus): the same molecule as Ozempic, reformulated for the stomach with SNAC.
- Only ~1% of the dose is absorbed, hence 3–14 mg tablets vs 0.25–1 mg injections.
- Strict fasting rules: empty stomach, small sip of water, wait 30 minutes before food.
- Daily dosing; PIONEER trials back glycemic control with class-typical GI side effects.
Overview
What it is
Oral semaglutide (Rybelsus) is the tablet form of the GLP-1 receptor agonist semaglutide, approved for type 2 diabetes. It co-formulates the peptide with SNAC, an absorption enhancer that lets it cross the stomach lining intact.
Pharmacokinetics
Oral bioavailability is only around 1%, which is why the milligram doses dwarf the injectable's. The plotter models a roughly 13-hour half-life and a peak near 90 minutes, with daily fasting doses building to steady state. The label requires an empty stomach, a small sip of water, and a 30-minute wait before food or other medications.
What the evidence says
The PIONEER phase 3 program is genuine RCT evidence: oral semaglutide improves glycemic control and reduces weight, with the class-typical gastrointestinal effects (nausea, vomiting, diarrhea) leading the adverse-event profile. Weight loss at labeled doses is more modest than with injectable semaglutide 2.4 mg.
Reported dosing protocols
Protocols reported in research literature and clinic/community use — informational context, not a dosing recommendation.
| Use case | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Type 2 diabetes (label) | 3 mg start, escalate to 7 mg after 30 days, then 14 mg if needed | Oral (fasting) | Once daily | Chronic |
Pharmacokinetic summary
- Model tier
- Advanced (t½ + Cmax + Tmax + F)
- Half-life
- 13.0 hours
- Cmax
- 232.38 nmol/L
- Tmax
- 0.1 days
- Bioavailability
- 1%
- Typical dose
- 3–14 mg
Frequently asked questions
Why does Rybelsus have to be taken fasting?
SNAC-enhanced absorption happens across the stomach lining and is easily disrupted: food, other medications, or a full glass of water cut the already-low ~1% bioavailability further. The label specifies up to 4 oz of water and a 30-minute wait before eating.
Oral vs injectable semaglutide — same drug?
Same molecule, different delivery. The tablet needs much higher milligram doses because roughly 99% is destroyed or unabsorbed, and it is taken daily while the injection is weekly. Weight loss at labeled doses is larger with the injectable.
Is oral semaglutide approved for weight loss?
No. Rybelsus carries a type 2 diabetes indication; the approved obesity product is injectable semaglutide 2.4 mg (Wegovy). Weight loss occurs on Rybelsus, but at labeled doses it is more modest.
References
- EMA Rybelsus assessment — Multiplier applied to align with injectable levels.
- Clinical Pharmacokinetics of Oral Semaglutide (Clin Pharmacokinet 2021) — Entry's PK source; pooled analysis of the clinical pharmacology trials.
- DailyMed — Rybelsus prescribing information — Label dosing, titration, and fasting administration rules.
Related compounds
Semaglutide Injection (Ozempic/Wegovy)
Long-acting GLP-1 receptor agonist for type 2 diabetes and weight loss; weekly injection.
Dulaglutide (Trulicity)
Long-acting GLP-1 agonist for type 2 diabetes and weight loss; weekly subcutaneous injection.
Tirzepatide (Mounjaro)
Dual GIP/GLP-1 agonist for weight loss and diabetes; weekly injection, strong efficacy.
Comments
Loading comments…